医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

AAV mediated carboxyl terminus of Hsp70 interacting protein overexpression mitigates the cognitive and pathological phenotypes of APP/PS1 mice

摘要The E3 ubiquitin ligase,carboxyl terminus of heat shock protein 70(Hsp70)interacting protein(CHIP),also functions as a co-chaperone and plays a crucial role in the protein quality control system.In this study,we aimed to investigate the neuroprotective effect of overexpressed CHIP on Alzheimer's disease.We used an adeno-associated virus vector that can cross the blood-brain barrier to mediate CHIP overexpression in APP/PS1 mouse brain.CHIP overexpression significantly ameliorated the performance of APP/PS1 mice in the Morris water maze and nest building tests,reduced amyloid-β plaques,and decreased the expression of both amyloid-β and phosphorylated tau.CHIP also alleviated the concentration of microglia and astrocytes around plaques.In APP/PS1 mice of a younger age,CHIP overexpression promoted an increase in ADAM10 expression and inhibited β-site APP cleaving enzyme 1,insulin degrading enzyme,and neprilysin expression.Levels of HSP70 and HSP40,which have functional relevance to CHIP,were also increased.Single nuclei transcriptome sequencing in the hippocampus of CHIP overexpressed mice showed that the lysosomal pathway and oligodendrocyte-related biological processes were up-regulated,which may also reflect a potential mechanism for the neuroprotective effect of CHIP.Our research shows that CHIP effectively reduces the behavior and pathological manifestations of APP/PS1 mice.Indeed,overexpression of CHIP could be a beneficial approach for the treatment of Alzheimer's disease.

更多
广告
作者 Zhengwei Hu [1] Jing Yang [2] Shuo Zhang [1] Mengjie Li [3] Chunyan Zuo [3] Chengyuan Mao [2] Zhongxian Zhang [4] Mibo Tang [5] Changhe Shi [2] Yuming Xu [2] 学术成果认领
作者单位 Department of Neurology,The First Affiliated Hospital of Zhengzhou University,Zhengzhou University,Zhengzhou,Henan Province,China;Academy of Medical Sciences of Zhengzhou University,Zhengzhou,Henan Province,China [1] Department of Neurology,The First Affiliated Hospital of Zhengzhou University,Zhengzhou University,Zhengzhou,Henan Province,China;NHC Key Laboratory of Prevention and treatment of Cerebrovascular Diseases,The First Affiliated Hospital of Zhengzhou University,Zhengzhou University,Zhengzhou,Henan Province,China;Henan Key Laboratory of Cerebrovascular Diseases,The First Affiliated Hospital of Zhengzhou University,Zhengzhou University,Zhengzhou,Henan Province,China;Institute of Neuroscience,Zhengzhou University,Zhengzhou,Henan Province,China [2] Department of Neurology,The First Affiliated Hospital of Zhengzhou University,Zhengzhou University,Zhengzhou,Henan Province,China [3] Sino-British Research Centre for Molecular Oncology,National Centre for International Research in Cell and Gene Therapy,School of Basic Medical Sciences,Academy of Medical Sciences,Zhengzhou University,Zhengzhou,Henan Province,China [4] Department of Gerontology,The First Affiliated Hospital of Zhengzhou University,Zhengzhou University,Zhengzhou,Henan Province,China [5]
DOI 10.4103/NRR.NRR-D-23-01277
发布时间 2024-12-24(万方平台首次上网日期,不代表论文的发表时间)
提交
  • 浏览7
  • 下载14
中国神经再生研究(英文版)

中国神经再生研究(英文版)

2025年20卷1期

253-264页

SCIMEDLINEISTICCSCDCABP

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷